J A Aarli. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdolescentAdultAnticonvulsants/administration & dosageAnticonvulsants/adverse effectsAnticonvulsants/therapeutic useBenzodiazepinones/administration & dosageBenzodiazepinones/adverse effectsBenzodiazepinones/therapeutic useCarbamazepine/therapeutic useChlorobenzenes/administration & dosageChlorobenzenes/adverse effectsChlorobenzenes/therapeutic useDrug EvaluationDrug Therapy, CombinationEpilepsy/drug therapyFatigue/chemically inducedFemaleHumansHydantoins/therapeutic useMaleNitro Compounds/administration & dosageNitro Compounds/adverse effectsNitro Compounds/therapeutic usePhenobarbital/therapeutic usePrimidone/therapeutic useThiazines/therapeutic useTime Factors
Substances： See more » AnticonvulsantsBenzodiazepinonesChlorobenzenesHydantoinsNitro CompoundsThiazinesPrimidoneCarbamazepinePhenobarbital
Year: 1973 PMID： 4148636 DOI： 10.1111/j.1600-0404.1973.tb02277.x
Source DB: PubMed Journal: Acta Neurol Scand Suppl ISSN： 0065-1427